Ip

© Madeleine_Steinbach / Getty Images

Aker BioMarine acquires IP & equipment from Acasti Pharma Inc.

By Stephen Daniells

Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All